INDBInternet News Database 2.5 Updated just now · 292 sources Show or hide images Light or dark

Miro clears TGA audit ahead of Crohn’s disease trial

1 source1 article First seen Updated Australia Truth score 42

Save Like Comments Compare coverage
Image from The Sydney Morning Herald

Summary

Miro Sciences has cleared a TGA manufacturing hurdle for its Crohn’s trial, with the regulator inspecting its partner’s facility ahead of a planned Phase 2 study for its StemSmart cell therapy.

Description from The Sydney Morning Herald.

Who is covering this

  1. The Sydney Morning Herald Leans left Factuality: High AU
    Miro clears TGA audit ahead of Crohn’s disease trial

    Miro Sciences has cleared a TGA manufacturing hurdle for its Crohn’s trial, with the regulator inspecting its partner’s facility ahead of a planned Phase 2 study for its StemSmart cell therapy.

Comments

Comments need JavaScript.